Laurence de Schoulepnikoff

Laurence de Schoulepnikoff has extensive work experience in various roles and industries. Laurence currently serves as the Chief Executive Officer of Tridek One since July 2022. Prior to that, Laurence was the Chief Operating/Business Officer at Amal Therapeutics from January 2019 to January 2022. In 2018, Laurence worked as the Senior Director of Business Development at Ferring Pharmaceuticals. From 2013 to 2017, Laurence held the position of the Head of Strategy, Transactions, and Legal at Stragen, where they were responsible for the company's transactions strategy, structuring, and negotiation. Laurence's earlier experience includes working at Novartis Consumer Health as the Global Business Development and Licensing Manager (2007-2013), Third Party Purchasing Manager (2002-2007), and the Supply Chain Manager (1998-2002). Before joining Novartis, Laurence worked at Dow Chemical as the TS&D Manager, where they were responsible for technical service in polyurethane technologies and led various projects in the furnishing, automotive, and construction industries.

Laurence de Schoulepnikoff obtained a Master's degree in Chemical Engineering from EPFL (École polytechnique fédérale de Lausanne) between 1987 and 1991.